ETS1 promotes cisplatin resistance of NSCLC cells by promoting GRP78 transcription

Ajoolabady A et al. (2023) Endoplasmic reticulum stress in liver diseases 77(2):619-639

Akinyemi AO et al (2023) Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review. Mol Med 29(1):112

Article  PubMed  PubMed Central  Google Scholar 

Alduais Y et al. (2023) Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment 102(8):e32899

Arab A et al (2017) Potential circulating miRNA signature for early detection of NSCLC. Cancer Genet 216–217:150–158

Article  PubMed  Google Scholar 

Ardic S et al (2019) The value of endoplasmic reticulum stress markers (GRP78 and CHOP) in the diagnosis of acute mesenteric ischemia. Am J Emerg Med 37(4):596–602

Article  PubMed  Google Scholar 

Bai Y et al (2023) Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer. Eur J Med Res 28(1):447

Article  PubMed  PubMed Central  Google Scholar 

Bailly C, Waring MJ (2019) Pharmacological effectors of GRP78 chaperone in cancers. Biochem Pharmacol 163:269–278

Article  PubMed  Google Scholar 

Basu A, Krishnamurthy S (2010) Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids 2010:201367

Article  PubMed  PubMed Central  Google Scholar 

Celik C et al (2023) Endoplasmic reticulum stress and lipids in health and diseases. Prog Lipid Res 89:101198

Article  PubMed  Google Scholar 

Chen W et al (2016) MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res 35:76

Article  PubMed  PubMed Central  Google Scholar 

Coughlin JM et al (2020) Understanding barriers to lung cancer screening in primary care. J Thorac Dis 12(5):2536–2544

Article  PubMed  PubMed Central  Google Scholar 

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

Article  PubMed  PubMed Central  Google Scholar 

Dauer P et al (2018) GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Mol Oncol 12(9):1498–1512

Article  PubMed  PubMed Central  Google Scholar 

English AR, Zurek N, Voeltz GK (2009) Peripheral ER structure and function. Curr Opin Cell Biol 21(4):596–602

Article  PubMed  PubMed Central  Google Scholar 

Guo W et al (2023) Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy. Eur J Med Chem 261:115792

Article  PubMed  Google Scholar 

Han J et al. (2024) SLC9A2, suppressing by the transcription suppressor ETS1, restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis. 39(1):238–251

Hetz C, Zhang K (2020) Mechanisms, regulation and functions of the unfolded protein response. 21(8):421-438

Ibrahim IM, Abdelmalek DH, Elfiky AA (2019) GRP78: A cell’s response to stress. Life Sci 226:156–163

Article  PubMed  PubMed Central  Google Scholar 

Ishteyaque S et al (2023) CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma. Arch Biochem Biophys 745:109701

Article  PubMed  Google Scholar 

Ji S et al. (2023) Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. 8(1):116

Jin T et al. (2021) iPLA(2)β Contributes to ER stress-induced apoptosis during myocardial ischemia/reperfusion injury. 10(6)

Lei Y et al (2024) Molecular mechanism of ATF6 in unfolded protein response and its role in disease. Heliyon 10(5):e25937

Article  PubMed  PubMed Central  Google Scholar 

Li J, Lee AS (2006) Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6(1):45–54

Article  PubMed  Google Scholar 

Liu Y et al (2024) ETS1-mediated Regulation of SOAT1 Enhances the Malignant Phenotype of Oral Squamous Cell Carcinoma and Induces Tumor-associated Macrophages M2-like Polarization. Int J Biol Sci 20(9):3372–3392

Article  PubMed  PubMed Central  Google Scholar 

Liu S et al. (2024) Targeting PAK4 reverses cisplatin resistance in NSCLC by modulating ER stress 10(1): 36

Luchtel RA (2024) ETS1 function in leukemia and lymphoma. Adv Exp Med Biol 1459:359–378

Article  PubMed  Google Scholar 

Mihailidou C et al (2015) Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress. Endocr Relat Cancer 22(2):229–238

Article  PubMed  Google Scholar 

Millien G et al. (2018) ETS1 regulates Twist1 transcription in a Kras(G12D)/Lkb1(-/-) metastatic lung tumor model of non-small cell lung cancer. 35(3):149–165

Mu W et al (2024) Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells. Front Pharmacol 15:1419468

Article  PubMed  PubMed Central  Google Scholar 

Qu WQ, Liu L, Yu Z (2015) Clinical value of microRNA-23a upregulation in non-small cell lung cancer. Int J Clin Exp Med 8(8):13598–13603

PubMed  PubMed Central  Google Scholar 

Ranganathan AC et al (2006) Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 66(3):1702–1711

Article  PubMed  PubMed Central  Google Scholar 

Roller C, Maddalo D (2013) The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment. Front Pharmacol 4:10

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD (2020) Cancer statistics. 2020.70(1):7–30

Tchounwou PB et al (2021) Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J Exp Pharmacol 13:303–328

Article  PubMed  PubMed Central  Google Scholar 

Tian G, Li J, Zhou L (2023) Ginsenoside Rg1 regulates autophagy and endoplasmic reticulum stress via the AMPK/mTOR and PERK/ATF4/CHOP pathways to alleviate alcohol‑induced myocardial injury. Int J Mol Med 52(1)

Wang Y et al (2023) ETS transcription factors: Multifaceted players from cancer progression to tumor immunity. Biochim Biophys Acta Rev Cancer 1878(3):188872

Article  PubMed  Google Scholar 

Wu D et al. (2023) Research progress on endoplasmic reticulum homeostasis in kidney diseases 14(7):473

Xia S et al. (2021) GRP78 in lung cancer 19(1):118

Xu M et al (2019) Lysophosphatidic acid induces integrin β6 expression in human oral squamous cell carcinomas cells via LPAR1 coupling to Gα(i) and downstream SMAD3 and ETS-1 activation. Cell Signal 60:81–90

Article  PubMed  Google Scholar 

Xu S et al (2023a) Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Front Immunol 14:1155182

Article  PubMed  PubMed Central  Google Scholar 

Xu J et al (2023b) Disturbance of neuron-microglia crosstalk mediated by GRP78 in Neuropsychiatric systemic lupus erythematosus mice. J Neuroinflammation 20(1):150

Article  PubMed  PubMed Central  Google Scholar 

Xu S et al (2024a) Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. BMC Cancer 24(1):1138

Article  PubMed  PubMed Central  Google Scholar 

Xu S et al (2024b) Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis. Front Immunol 15:1433299

Article  PubMed  PubMed Central  Google Scholar 

Xu S et al (2024c) Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response. BMC Cancer 24(1):1064

Article  PubMed  PubMed Central  Google Scholar 

Xu S, Lu Z (2024) The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma. Asian J Surg

Yang S et al (2016) microRNA-361 targets Wilms’ tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells. Mol Med Rep 14(6):5415–5421

Art

留言 (0)

沒有登入
gif